Health Catalyst, Inc. (HCAT) grants 80,691 RSUs to board member

Rhea-AI Filing Summary

Spencer Justin reported acquisition or exercise transactions in this Form 4 filing.

Health Catalyst, Inc. reported that director Justin Spencer received an equity award of 80,691 restricted stock units (RSUs) of common stock. Each RSU represents a contingent right to one share.

Under the 2019 Stock Option and Incentive Plan, these RSUs fully vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders. Following this award, Spencer directly holds 149,263 shares of common stock.

Insider Trade Summary

Net Buyer: 80,691 shares

Net Buy 1 txn

Insider Spencer Justin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	80,691	$0.00	--

Holdings After Transaction: Common Stock — 149,263 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Key Figures

RSU award size: 80,691 RSUs Shares held after grant: 149,263 shares Grant price per share: $0.0000 per share

3 metrics

RSU award size 80,691 RSUs Restricted stock units of common stock granted to director Justin Spencer

Shares held after grant 149,263 shares Total direct holdings of Justin Spencer following the RSU award

Grant price per share $0.0000 per share Reported per-share price for the RSU compensation award

Key Terms

restricted stock units, 2019 Stock Option and Incentive Plan, Annual Meeting of the Issuer's Stockholders, contingent right

4 terms

restricted stock units financial

"Represents an award of restricted stock units ("RSUs") granted pursuant"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2019 Stock Option and Incentive Plan financial

"granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan"

Annual Meeting of the Issuer's Stockholders financial

"the date of the next Annual Meeting of the Issuer's Stockholders"

contingent right financial

"Each RSU represents a contingent right to receive one share"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/20/2026 - 05:19 PM Accepted by SEC EDGAR 07/20/2026 - 05:18 PM Learn about SEC filing dates

FAQ

What equity award did Health Catalyst (HCAT) director Justin Spencer receive?

Director Justin Spencer received an award of 80,691 restricted stock units (RSUs) of Health Catalyst common stock. Each RSU equals one share and is granted as compensation rather than a market purchase, increasing his direct holdings to 149,263 shares after the grant.

How do the new RSUs for Health Catalyst (HCAT) director Justin Spencer vest?

The 80,691 RSUs granted to Justin Spencer fully vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders. Vesting remains subject to the terms and conditions of the company’s 2019 Stock Option and Incentive Plan.

What is Justin Spencer’s total direct shareholding in Health Catalyst (HCAT) after this grant?

After the RSU award, Justin Spencer directly holds 149,263 shares of Health Catalyst common stock. This figure reflects his position immediately following the grant of 80,691 restricted stock units reported in the insider transaction.

What plan governs the RSU grant reported for Health Catalyst (HCAT) director Justin Spencer?

The award to Justin Spencer was granted under Health Catalyst’s 2019 Stock Option and Incentive Plan. This plan sets the terms for RSUs, including vesting conditions, and specifies that each RSU represents a contingent right to receive one share of common stock.

Does the Health Catalyst (HCAT) RSU grant to Justin Spencer involve a cash purchase price?

The RSU grant to Justin Spencer carries a reported per-share price of $0.0000, reflecting that it is a compensatory equity award rather than a cash purchase. The value he ultimately receives depends on the number of RSUs that vest and the share price at settlement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spencer Justin

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		80,691(1)	A	$0.00	149,263	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)